FDA Investigator Mercy O Quagraine
Mercy O Quagraine has conducted inspections on 5 sites in 1 countries as of 09 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Mercy O Quagraine:
Alia Legaux,
Amy Wyan Mai,
Angela E Glenn,
Barbara T Carmichael,
Bradley Dworak, PhD,
Burnell M Henry,
Chad R Burger,
Darla J Christopher,
Dr. Gang Wang, PhD,
Dwayne E Dollins,
Ekaterina Allen,
Evelyn Taha,
Gene D Arcy,
Gloria E Parra,
Haydee B Romero,
Heba A Degheidy,
Helen B Ricalde,
Holly M Scott,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
Joyce A Rockwell,
Justin A Boyd,
Laura M Howard,
Laura Schankweiler,
Lauren M Lilly, PhD,
LCDR Randall L Morris,
Leena Thomas,
Lily Y Koo,
Lisa Mathew,
LTJG Matthew R Palo,
Madelyn Renteria,
Marion Michaelis,
Matthew W Klinker,
Mizanne E Lewis,
Mohammad Heidaran, PhD,
Nancy T Waites,
Nicole K Trudel,
Nimmy Mathews,
Peter Abel,
Prabhu P Raju,
Randa Melhem, PhD,
Randy L Clarida,
Simone E Pitts,
Sukhanya Jayachandra,
Susan M Jackson,
Thomas Finn, PhD,
Valerie Jgrecek Trinh
Mercy O Quagraine's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2016 | FDA 483 Response | Carolinas Cord Blood Bank - Form 483R, 2016-01-26 |
January, 2016 | FDA 483 | Carolinas Cord Blood Bank - Form 483, 2016-01-12 |
July, 2018 | FDA 483 | LifeSouth Community Blood Centers, Inc - Form 483, 2018-07-24 |
January, 2016 | EIR | Carolinas Cord Blood Bank - EIR, 2016-01-12 |
November, 2017 | FDA 483 | New York Blood Center, Inc. - Form 483, 2017-11-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more